Phosphatidylethanolamine of Helicobacter pylori functions as a steroid-binding lipid in the assimilation of free cholesterol and 3β-hydroxl steroids into the bacterial cell membrane

Journal of Bacteriology

Volumn 194, Issue 10, 2012, Pages 2658-2667

  Shimomura, Hirofumi ^a   Hosoda, Kouichi ^a   Hayashi, Shunji ^a   Yokota, Kenji ^b   Hirai, Yoshikazu ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,6 O DIMETHYL BETA CYCLODEXTRIN; 3 BETA HYDROXYL STEROID; CHOLESTEROL; CHOLESTEROL ESTER; FATTY ACID; PHOSPHATIDYLETHANOLAMINE; PRASTERONE; PREGNENOLONE; STEROID; STEROID BINDING LIPID; STEROID BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL MEMBRANE; BINDING AFFINITY; ESCHERICHIA COLI; HELICOBACTER PYLORI; HYDROPHOBICITY; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION;

BETA-CYCLODEXTRINS; BIOLOGICAL TRANSPORT; CELL MEMBRANE; CHOLESTEROL; CHOLESTEROL ESTERS; HELICOBACTER PYLORI; HYDROXYSTEROIDS; LIPID METABOLISM; MOLECULAR STRUCTURE; PHOSPHATIDYLETHANOLAMINES; STEROIDS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; HELICOBACTER PYLORI;

EID: 84861414398     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00105-12     Document Type: Article

References (32)

1. Amine A, Saloua KS, Mouadh M, Alya EIM, Ahmed L. 2011. The absence of the "GATC-binding protein SeqA" affects DNA replication in Salmonella enterica serovar Typhimurium. In Kusic-Tisma J (ed), DNA replication and related cellular processes. InTech, Rijeka, Croatia. http://www.intechopen.com/books/dna-replication-and-related-cellular-processes/the-absence-of-the-gatc-binding-protein-seqa-affects-dna-replication-in-salmonella-enterica-serovar-.
2. Anderson TG, Tan A, Ganz P, Seelig J. 2004. Calorimetric measurement of phospholipid interaction with methyl-β-cyclodextrin. Biochemistry 43:2251-2261.
3. Arima H, Yunomae K, Morikawa T, Hirayama F, Uekama K. 2004. Contribution of cholesterol and phospholipids to inhibitory effect of dimethyl-β-cyclodextrin on efflux function of P-glycoprotein and multidrug resistance-associated protein 2 in vinblastine-resistant Caco-2 cell monolayers. Pharm. Res. 21:625-634.
4. Douraghi M, et al. 2010. Comparative evaluation of three supplements for Helicobacter pylori growth in liquid culture. Curr. Microbiol. 60:254-262.
5. Dunnick JK, O'Leary WM. 1970. Correlation of bacterial lipid composition with antibiotic resistance. J. Bacteriol. 101:892-900.
6. Fukasawa M, Nishijima M, Itabe H, Takano T, Hanada K. 2000. Reduction of sphingomyelin level without accumulation of ceramide in Chinese hamster ovary cells affects detergent-resistant membrane domains and enhances cellular cholesterol efflux to methyl-betacyclodextrin. J. Biol. Chem. 275:34028-34034.
7. Fukase K, et al. 2008. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 372:392-397.
8. Graham DY. 1991. Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease. J. Gastroenterol. Hepatol. 6:105-113.
9. Hirai Y, et al. 1995. Unique cholesteryl glucosides in Helicobacter pylori: composition and structural analysis. J. Bacteriol. 177:5327-5333.
10. Hosoda K, et al. 2009. Anabolic utilization of steroid hormones in Helicobacter pylori. FEMS Microbiol. Lett. 297:173-179.
11. Hosoda K, Shimomura H, Hayashi S, Yokota K, Hirai Y. 2011. Steroid hormones as bactericidal agents to Helicobacter pylori. FEMS Microbiol. Lett. 318:68-75.
12. Junquera E, Peña L, Aicart E. 1998. Binding of sodium salicylate by β-cyclodextrin or 2,6-di-O-methyl-β-cyclodextrin in aqueous solution. J. Pharm. Sci. 87:86-90.
13. Kearns DB, Robinson J, Shimkets LJ. 2001. Pseudomonas aeruginosa exhibits directed twitching motility up phosphatidylethanolamine gradients. J. Bacteriol. 183:763-767.
14. Lebrun A, et al. 2006. Cloning of a cholesterol-β-glucosyltransferase from Helicobacter pylori. J. Biol. Chem. 281:27765-27772.
15. Marchini A, et al. 1995. Cyclodextrins for growth of Helicobacter pylori and production of vacuolating cytotoxin. Arch. Microbiol. 164:290-293.
16. Marshall B, Warren JR. 1983. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet i:1273-1274.
17. McGee DJ, et al. 2011. Cholesterol enhances Helicobacter pylori resistance to antibiotics and LL-37. Antimicrob. Agents Chemother. 55:2897-2904.
18. 2+ mobilization. Pharmacologist 44:A68.
19. Peek RM, Jr, Blaser MJ. 2002. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2:28-37.
20. Peek RM, Jr, Crabtree JE. 2006. Helicobacter infection and gastric neoplasia. J. Pathol. 208:233-248.
21. Rietschel ET, et al. 1994. Bacterial endotoxin: molecular relationship of structure to activity and function. FASEB J. 8:217-225.
22. Shimomura H, Hayashi S, Yokota K, Oguma K, Hirai Y. 2004. Alteration in the composition of cholesteryl glucosides and other lipids in Helicobacter pylori undergoing morphological change from spiral to coccoid form. FEMS Microbiol. Lett. 237:407-413.
23. Shimomura H, et al. 2009. Steroids mediate resistance to the bactericidal effect of phosphatidylcholines against Helicobacter pylori. FEMS Microbiol. Lett. 301:84-94.
24. Shokri A, Larsson G. 2004. Characterisation of the Escherichia coli membrane structure and function during fed batch cultivation. Microb. Cell Fact. 3:9.
25. Stolte M, et al. 2002. Helicobacter and gastric MALT lymphoma. Gut 50:III19 -III24.
26. Trainor EA, Horton KE, Savage PE, Testerman TL, McGee DJ. 2011. Role of the HefC efflux pump in Helicobacter pylori cholesterol-dependent resistance to ceragenins and bile salts. Infect. Immun. 79:88-97.
27. Uemura N, et al. 2001. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345:784-789.
28. Wunder C, et al. 2006. Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat. Med. 12:1030-1038.
29. Wyatt JI, Dixon MF. 1988. Chronic gastritis-a pathogenetic approach. J. Pathol. 154:113-124.
30. Yamashita T, Yamaguchi T, Murakami K, Nagasawa S. 2001. Detergentresistant membrane domains are required for mast cell activation but dispensable for tyrosine phosphorylation upon aggregation of the high affinity receptor for IgE. J. Biochem. 129:861-868.
31. Yu Z, et al. 2007. Investigation of heptakis (2,6-di-O-methyl)-β-cyclodextrin inclusion complexes with flavonoid glucosides by electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 21: 683-690.
32. Yunomae K, Arima H, Hirayama F, Uekama K. 2003. Involvement of cholesterol in the inhibitory effect of dimethyl-β-cyclodextrin on P-glycoprotein and MRP2 function in Caco-2 cells. FEBS Lett. 536:225-231.